Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy
NCT01910532Phase 4Withdrawn
- Start
- Apr 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clevidipine in hypertension (HTN). Planned start Apr 2010; status: withdrawn.
02
Drugs
clevidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01910532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01910532.